Market News AIOpen the app

Truist Securities increased its target price for Ardent Health, Inc. to $22 from $13.

OpinionRead the original at marketscreener.com
Good for ARDT

Truist raised its target for Ardent Health shares and kept its Buy rating, supporting a more positive view of the shares. The report gives no new company results or care updates.

ARDT · Ardent Health, Inc.

AI read · Good for ARDT

The AI's read

That change shows Truist sees Ardent Health shares more favorably after assessing the company's position and financial prospects. The report gives no new sales, profit, or care updates, so the positive read comes from the analyst's view alone.

Get alerts for ARDT

Follow Ardent Health, Inc. (ARDT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ARDT
Free on the App Store and Google Play, or on the web.